2023-03-30T16:58:22+08:00 weekly 1.0 https://nl.prisysbiotech.com/ 2024-11-09T00:43:45+08:00 weekly 0.9 https://nl.prisysbiotech.com/animal-welfare 2024-11-09T00:43:51+08:00 weekly 0.9 https://nl.prisysbiotech.com/ophthalmic-disease-research 2024-11-09T00:43:54+08:00 weekly 0.9 https://nl.prisysbiotech.com/respiratory-disease-research 2024-11-09T01:03:23+08:00 weekly 0.9 https://nl.prisysbiotech.com/metabolic-syndromes-research 2023-04-01T08:57:02+08:00 weekly 0.9 https://nl.prisysbiotech.com/co-develop 2024-11-09T00:43:48+08:00 weekly 0.9 https://nl.prisysbiotech.com/hematological-disease-research 2024-11-09T00:43:53+08:00 weekly 0.9 https://nl.prisysbiotech.com/cns-disorders-behavior-analysis 2024-11-09T00:43:51+08:00 weekly 0.9 https://nl.prisysbiotech.com/inflammation-immunology-disorders 2024-11-09T00:43:42+08:00 weekly 0.9 https://nl.prisysbiotech.com/translational-research-center 2026-08-08T20:20:13+08:00 weekly 0.9 https://nl.prisysbiotech.com/download 2024-09-29T14:45:25+08:00 weekly 0.9 https://nl.prisysbiotech.com/nephrology 2024-09-29T14:23:03+08:00 weekly 0.9 https://nl.prisysbiotech.com/fibrosis 2024-11-09T00:43:42+08:00 weekly 0.9 https://nl.prisysbiotech.com/about-us 2024-11-09T00:43:42+08:00 weekly 0.9 https://nl.prisysbiotech.com/contact-us 2023-04-01T08:56:55+08:00 weekly 0.9 https://nl.prisysbiotech.com/newslist-1 2024-11-09T00:43:42+08:00 weekly 0.9 https://nl.prisysbiotech.com/products 2023-04-01T08:27:06+08:00 weekly 1.0 https://nl.prisysbiotech.com/nhp-pharmacology/ 2023-04-01T08:27:08+08:00 weekly 0.9 https://nl.prisysbiotech.com/pk-pd-adme/ 2023-04-01T08:27:10+08:00 weekly 0.9 https://nl.prisysbiotech.com/translation-research/ 2023-04-01T08:27:11+08:00 weekly 0.9 https://nl.prisysbiotech.com/safety-evaluation/ 2023-04-01T08:39:18+08:00 weekly 0.9 https://nl.prisysbiotech.com/biosafety-research/ 2024-04-09T07:37:41+08:00 weekly 0.9 https://nl.prisysbiotech.com/clearpoint/ 2026-08-13T16:49:35+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html 2024-11-09T00:43:54+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html 2023-04-01T08:56:41+08:00 weekly 0.8 https://nl.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html 2024-11-09T00:43:41+08:00 weekly 0.8 https://nl.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html 2024-11-09T00:43:55+08:00 weekly 0.8 https://nl.prisysbiotech.com/pk-pd-adme/toxicokinetics.html 2023-04-01T08:56:42+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/non-human-primate.html 2024-11-09T00:43:45+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html 2024-11-09T00:43:47+08:00 weekly 0.8 https://nl.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html 2024-11-09T00:43:45+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html 2023-04-01T08:56:48+08:00 weekly 0.8 https://nl.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html 2024-11-09T00:43:45+08:00 weekly 0.8 https://nl.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html 2024-11-09T00:43:43+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html 2023-04-01T08:56:43+08:00 weekly 0.8 https://nl.prisysbiotech.com/pk-pd-adme/adme.html 2023-04-01T08:56:48+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html 2023-04-01T08:56:50+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html 2023-04-01T08:56:50+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html 2023-04-01T08:56:55+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html 2024-11-09T00:43:38+08:00 weekly 0.8 https://nl.prisysbiotech.com/translation-research/nhpresources.html 2024-11-09T01:03:22+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html 2023-04-01T08:56:46+08:00 weekly 0.8 https://nl.prisysbiotech.com/safety-evaluation/toxicology.html 2023-04-01T08:56:49+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html 2024-11-09T00:43:46+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html 2024-11-09T00:43:42+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html 2023-04-01T08:56:48+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html 2024-11-09T00:43:45+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html 2023-04-01T08:56:49+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html 2023-04-01T08:56:52+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html 2024-11-09T00:43:47+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html 2024-11-09T00:43:48+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html 2026-08-13T16:50:24+08:00 weekly 0.8 https://nl.prisysbiotech.com/safety-evaluation/immunotoxicity.html 2023-04-01T08:56:49+08:00 weekly 0.8 https://nl.prisysbiotech.com/translation-research/translational-studies.html 2024-11-09T00:43:59+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html 2024-11-09T00:43:43+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html 2023-04-01T08:56:51+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html 2024-11-09T00:43:42+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html 2024-11-09T00:43:48+08:00 weekly 0.8 https://nl.prisysbiotech.com/biosafety-research/biosafetyresearch.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html 2024-11-09T00:43:53+08:00 weekly 0.8 https://nl.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html 2024-11-09T00:43:58+08:00 weekly 0.8 https://nl.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html 2024-11-09T00:43:39+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html 2024-11-09T00:44:09+08:00 weekly 0.8 https://nl.prisysbiotech.com/translation-research/clinical-imaging.html 2024-09-29T20:16:04+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html 2024-09-29T20:16:05+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html 2024-09-29T20:16:06+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html 2024-09-29T20:16:06+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html 2024-11-09T00:43:56+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html 2024-09-29T20:16:14+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html 2024-09-29T20:16:24+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html 2024-12-07T15:55:14+08:00 weekly 0.8 https://nl.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html 2024-12-08T01:49:20+08:00 weekly 0.8 https://nl.prisysbiotech.com/clearpoint/nhp-neuroscience.html 2025-04-01T18:17:26+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html 2025-04-01T18:51:26+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html 2025-07-20T23:02:43+08:00 weekly 0.8 https://nl.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html 2025-07-20T23:02:45+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html 2025-08-24T09:54:41+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html 2025-09-14T17:54:48+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html 2025-09-21T18:33:10+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html 2025-09-27T04:35:48+08:00 weekly 0.8 https://nl.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html 2025-10-04T11:02:48+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html 2025-12-25T19:28:59+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html 2026-01-29T22:07:37+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html 2026-05-03T13:47:02+08:00 weekly 0.8 https://nl.prisysbiotech.com/translation-research/dsa-guided-interventional-platform.html 2026-05-03T13:47:28+08:00 weekly 0.8 https://nl.prisysbiotech.com/pk-pd-adme/nhp-intracerebral-injection-icm-services.html 2026-05-03T13:47:34+08:00 weekly 0.8 https://nl.prisysbiotech.com/translation-research/biodistribution-imaging-service.html 2026-05-03T13:47:39+08:00 weekly 0.8 https://nl.prisysbiotech.com/pk-pd-adme/nhp-intrathecal-dosing-csf-sampling.html 2026-05-25T19:08:23+08:00 weekly 0.8 https://nl.prisysbiotech.com/nhp-pharmacology/nhp-focal-segmental-glomerulosclerosis-fsgs.html 2026-05-25T19:08:26+08:00 weekly 0.8 https://nl.prisysbiotech.com/pk-pd-adme/nhp-intracerebroventricular-icv-injection.html 2023-04-01T08:27:06+08:00 weekly 0.9 https://nl.prisysbiotech.com/newslist-714358-1 2023-04-01T08:27:10+08:00 weekly 0.9 https://nl.prisysbiotech.com/newslist-714359-1 2024-08-01T00:33:17+08:00 weekly 0.9 https://nl.prisysbiotech.com/newslist-819320-1 2026-05-03T13:46:38+08:00 weekly 0.9 https://nl.prisysbiotech.com/newslist-17856908444902400-1 2023-04-01T08:56:37+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66135896.html 2023-04-01T08:56:42+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/prisys-sot2023-66135897.html 2023-04-01T08:56:38+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/meetprisys-sot2023-66135898.html 2026-09-01T21:27:44+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/gene-therapy-nhp-model-66135899.html 2023-04-01T08:56:43+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66135900.html 2026-09-01T21:27:19+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66135901.html 2023-04-01T08:56:38+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66135902.html 2026-09-01T21:27:25+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66135903.html 2026-09-01T21:28:34+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66135904.html 2026-09-01T21:27:14+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66136628.html 2026-09-01T21:28:53+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/gene-therapy-toxicology-66276507.html 2026-09-01T21:32:33+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67546358.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/world-parkinsons-disease-day-67548245.html 2026-09-01T21:39:35+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67549529.html 2026-09-01T21:39:35+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67552207.html 2026-09-01T21:39:30+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67552774.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67559977.html 2026-09-01T21:32:30+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67561314.html 2026-09-01T21:39:35+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67580180.html 2026-09-01T21:39:36+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68124562.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68124563.html 2026-09-01T21:39:36+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68124564.html 2026-09-01T21:32:30+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68124565.html 2026-09-01T21:32:31+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68306735.html 2026-09-01T21:32:37+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-69011846.html 2026-09-01T21:32:46+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69011985.html 2026-09-01T21:32:35+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69012879.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-69013089.html 2026-09-01T21:32:37+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69013184.html 2026-09-01T21:32:38+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69014169.html 2026-09-01T21:32:42+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309373.html 2026-09-01T21:39:39+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309394.html 2026-09-01T21:32:42+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309397.html 2026-09-01T21:39:36+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309405.html 2026-07-21T08:19:57+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69654825.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69661932.html 2026-09-01T21:32:45+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-70986492.html 2026-09-01T21:32:46+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-70986493.html 2026-09-01T21:32:48+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/0-70986494.html 2026-09-01T21:32:49+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-70986495.html 2026-09-01T21:32:51+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-70986496.html 2026-09-01T21:32:43+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-70986497.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72330137.html 2026-09-01T21:33:05+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72330139.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72330140.html 2026-09-01T21:32:51+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72330141.html 2026-09-01T21:32:52+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72330142.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72708933.html 2026-09-01T21:33:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73027152.html 2026-09-01T21:32:47+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73639614.html 2026-09-01T21:32:48+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73639615.html 2026-07-21T08:20:15+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74210430.html 2026-09-01T21:32:52+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74693106.html 2026-09-01T21:32:49+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74810506.html 2026-09-01T21:32:58+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75175376.html 2026-09-01T21:32:50+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75175377.html 2026-09-01T21:32:58+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76192272.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77076740.html 2026-09-01T21:32:52+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77745605.html 2024-11-09T00:43:35+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77746782.html 2026-09-01T21:32:57+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/nhp-asthma-model-79203756.html 2026-09-01T21:32:53+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79203769.html 2026-09-01T21:32:55+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79203778.html 2026-09-01T21:32:55+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79203780.html 2026-09-01T21:32:59+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79203782.html 2024-11-09T00:43:37+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79476691.html 2026-09-01T21:32:52+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79476692.html 2026-09-01T21:32:55+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79476693.html 2026-09-01T21:33:01+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79541402.html 2026-09-01T21:32:52+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/pk-strategies-of-pdc-79541404.html 2026-09-01T21:33:00+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79541406.html 2026-09-01T21:32:58+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79541407.html 2026-09-01T21:33:03+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79541410.html 2026-09-01T21:33:00+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79541411.html 2026-09-01T21:33:02+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79541412.html 2026-09-01T21:32:58+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79541413.html 2026-09-01T21:33:13+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79541414.html 2026-09-01T21:33:01+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79541415.html 2026-09-01T21:33:00+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79541416.html 2026-09-01T21:33:02+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79541417.html 2026-09-01T21:33:03+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79541418.html 2026-09-01T21:33:00+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79541419.html 2026-09-01T21:32:57+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79541420.html 2026-09-01T21:33:01+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79541421.html 2026-09-01T21:32:55+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79541422.html 2026-09-01T21:33:09+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79541423.html 2026-09-01T21:33:03+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79541424.html 2026-09-01T21:32:58+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79541425.html 2026-09-01T21:33:04+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79541426.html 2026-09-01T21:33:02+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79541427.html 2026-09-01T21:33:03+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79541428.html 2026-09-01T21:32:58+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79541429.html 2026-09-01T21:33:04+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79541430.html 2026-09-01T21:33:06+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79541431.html 2026-09-01T21:33:01+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79541432.html 2026-09-01T21:33:07+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79541433.html 2026-09-01T21:33:04+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79541434.html 2026-09-01T21:33:14+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79541435.html 2026-09-01T21:33:08+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79541437.html 2026-09-01T21:33:05+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79541438.html 2026-09-01T21:33:05+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79541439.html 2026-09-01T21:33:07+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79541440.html 2026-09-01T21:33:01+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79541441.html 2026-09-01T21:33:26+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/mrna-based-therapies-past-79541442.html 2026-09-01T21:33:17+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79541443.html 2026-09-01T21:33:04+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/significance-principles-and-requirements-of-79541444.html 2026-09-01T21:33:05+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79541445.html 2026-09-01T21:33:17+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79541446.html 2026-09-01T21:33:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79541447.html 2026-09-01T21:33:08+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79541448.html 2026-09-01T21:33:22+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79541449.html 2026-09-01T21:33:23+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/mrna-based-therapies-present-79541450.html 2026-09-01T21:33:17+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79541451.html 2026-09-01T21:33:36+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79541452.html 2026-09-01T21:33:19+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79542162.html 2026-09-01T21:33:29+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656498.html 2026-09-01T21:33:27+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81216027.html 2026-09-01T21:34:06+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81216029.html 2026-09-01T21:33:45+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81216030.html 2026-09-01T21:33:33+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/convection-enhanced-delivery-81216036.html 2026-09-01T21:34:03+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/china-experimental-monkey-industry-81216037.html 2026-09-01T21:35:25+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81216040.html 2026-09-01T21:33:34+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81216044.html 2026-09-01T21:33:56+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81216046.html 2026-09-01T21:34:23+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/animal-models-of-human-diseases-81216047.html 2026-09-01T21:35:41+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81216051.html 2026-09-01T21:33:35+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/compartment-pk-model-81216125.html 2026-09-01T21:33:36+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/human-disease-animal-models-81216608.html 2026-09-01T21:33:39+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81216610.html 2026-09-01T21:39:10+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82265889.html 2026-09-01T21:39:11+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82728339.html 2026-09-01T21:39:04+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82728340.html 2026-09-01T21:39:15+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82728341.html 2026-09-01T21:39:20+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82728342.html 2026-09-01T21:39:20+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82728343.html 2026-09-01T21:39:12+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82728344.html 2026-09-01T21:39:15+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82728346.html 2026-09-01T21:39:17+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82728348.html 2026-09-01T21:39:39+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82728788.html 2026-09-01T21:39:33+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83021680.html 2026-09-01T21:39:35+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83025718.html 2026-09-01T21:39:19+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83027517.html 2026-09-01T21:39:24+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-83977890.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-83977891.html 2026-09-01T21:39:25+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-83977896.html 2026-09-01T21:39:27+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-83977897.html 2026-09-01T21:39:22+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-83977903.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-83977913.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-83977918.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-83977933.html 2026-09-01T21:39:31+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-83977948.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17243164351325184.html 2026-09-01T21:39:34+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17243164406064128.html 2026-09-01T21:39:24+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/animal-models-for-womens-health-17295190285902848.html 2026-09-01T21:39:32+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17295190324716544.html 2026-07-21T08:20:27+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/membranous-nephropathy-model-17295190345147392.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17295190419645440.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17295190737757184.html 2026-09-01T21:39:32+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17295190747833344.html 2026-07-21T08:20:37+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17295190760023040.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17295223682900992.html 2026-07-21T08:20:14+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17295223689323520.html 2026-09-01T21:39:27+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17295223697941504.html 2026-09-01T21:39:22+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17295223711622144.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17295223773815808.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17295223868957696.html 2026-09-01T21:39:22+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17295223967835136.html 2026-07-21T09:01:27+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17295224031355904.html 2026-09-01T21:39:35+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17295261541884928.html 2026-07-21T08:20:24+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17298411422573568.html 2026-09-01T21:39:22+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17374208996238336.html 2026-07-21T08:20:47+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17374209021666304.html 2026-07-21T08:20:25+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17374209030710272.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17374209045898240.html 2026-09-01T21:39:28+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17374209071358976.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17374209110516736.html 2026-09-01T21:39:28+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17374209113678848.html 2026-07-21T08:20:28+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/intracerebroventricular-icv-injection-17374209136124928.html 2026-07-21T08:21:02+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17374209244275712.html 2026-07-21T08:20:23+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17374209374659584.html 2026-07-21T08:20:48+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17374209469195264.html 2026-07-21T08:20:31+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17374251511063552.html 2026-09-01T21:39:30+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17451184334627840.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17451184456655872.html 2026-07-21T08:20:39+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17451184488506368.html 2026-09-01T21:39:38+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17451184525779968.html 2026-09-01T21:39:33+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17451184541410304.html 2026-07-21T08:20:29+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/key-considerations-for-dosing-volume-17451184551896064.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17451184638239744.html 2026-07-21T08:20:58+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17451184788939776.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17451219807429632.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17451219940664320.html 2026-07-21T08:20:40+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17451219982640128.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17451220126376960.html 2025-08-24T09:54:53+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17499935841657856.html 2026-09-01T21:39:33+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17499935906702336.html 2026-09-01T21:39:36+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17499935921087488.html 2025-08-24T09:54:50+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17499935941518336.html 2025-08-24T09:54:49+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/nhp-copd-model-17499935962194944.html 2025-08-24T09:55:04+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17499935998551040.html 2025-09-14T17:54:54+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/brain-targeted-drug-delivery-17530136501232640.html 2025-09-14T17:54:57+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17530136642069504.html 2026-07-21T08:20:36+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17530136687780864.html 2026-09-01T21:39:35+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17530136964047872.html 2025-09-14T17:54:58+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17530137149481984.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/the-importance-of-administration-volume-17530154150028288.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17530154186368000.html 2026-09-01T21:39:36+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17540100810499072.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17558060762801152.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17640758354977792.html 2026-09-01T21:39:31+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17640797104514048.html 2026-07-21T08:20:18+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17640797222069248.html 2026-09-01T21:39:33+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17640797245891584.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/rfp-template-for-nhp-studies-17640797319341056.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17640797526582272.html 2026-09-01T21:39:41+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17640797592626176.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17640797606650880.html 2026-07-21T08:21:02+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/nhp-renal-biopsy-17640797647152128.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17640797927040000.html 2026-09-01T21:39:35+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17640834569577472.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17674635526743040.html 2026-07-21T08:20:28+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674635575567360.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674635584300032.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674635604468736.html 2026-07-21T08:21:49+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674635652015104.html 2026-09-01T21:39:37+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674635666777088.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674635741897728.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674635810956288.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674635844133888.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724336490669056.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724336555385856.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724336557319168.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724336593249280.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724336599589888.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724336609944576.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724336628818944.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724336662045696.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724336669221888.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724336905233408.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/ai-markerless-nhp-3d-behavior-analysis-system-17856908465513472.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/ipf-drug-development-nhp-ct-imaging-pft-17856908535964672.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/mri-guided-cns-delivery-in-nhp-models-17856908543108096.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/nhp-cns-biodistribution-studies-intrathecal-17856908554691584.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/drug-development-reliance-on-nhp-models-17856908592227328.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/large-animal-radiolabeling-and-in-vivo-imaging-17856908601402368.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/evaluating-dmpk-properties-17856908635300864.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/nonlinear-pharmacokinetics-nhp-pkpd-17856908686304256.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/prisys-supports-ind-approval-of-ux-gip001-17856908708226048.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-antibody-safety-17856908741125120.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/translational-pk-pd-framework-cynomolgus-17856908760736768.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/pet-ct-biodistribution-in-nhp-models-for-cns-17856908769354752.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/nonclinical-pharmacokinetics-strategy-17856908824323072.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/non-glp-pharmacology-data-integrity-17856908854141952.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/dopamine-transporter-pet-imaging-in-nhp-models-17856908899034112.html 2026-05-03T14:13:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/in-vivo-immune-cell-tracking-17856922690069504.html 2026-05-25T19:11:43+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/pk-data-as-pharmacodynamic-biomarker-17888354620531712.html 2026-05-25T19:10:30+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/nhp-models-translational-drug-development-17888355832570880.html 2026-05-25T19:10:53+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/non-human-primate-models-of-pulmonary-fibrosis-17888356184204288.html 2026-07-21T11:41:25+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/pk-data-as-translational-biomarker-17888361163777024.html 2026-07-21T11:41:23+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/on-demand-webinar-mri-ced-nhp-17888367380243456.html 2026-07-21T11:41:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/nhp-heart-failure-model-17941518137385984.html 2026-07-21T11:41:23+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-17941518139941888.html 2026-07-21T11:41:11+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/nonlinear-pharmacokinetics-explained-17941518200824832.html 2026-07-21T11:41:29+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/what-is-molecular-imaging-drug-development-17941518283908096.html 2026-07-21T11:41:20+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/nhp-molecular-imaging-translational-pet-studie-17941518340695040.html 2026-07-21T11:41:27+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/dsa-cta-cardiovascular-drug-safety-imaging-17941518357111808.html 2026-07-21T11:41:16+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/molecular-imaging-biomarkers-advancing-transl-17941518384587776.html 2026-07-21T11:41:32+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/nhp-radionuclide-biodistribution-17941518386127872.html 2026-07-21T08:20:31+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/clinical-pathology-interpretation-dogs-nhp-17941533068518400.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/pain-mechanisms-the-uvb-sunburn-model-17968418247287808.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/ai-nhp-behavioral-analysis-17968418300617728.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/nhp-models-of-maternal-high-fat-diet-and-child-17968418328536064.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/nhp-behavioratlas-3d-behavioral-tracking-17968458512606208.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/nhp-aav-gene-therapy-model-mri-guided-ced-17975299704038400.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/markerless-3d-nhp-behavior-analysis-17975299710542848.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/baseline-ada-screening-washed-out-monkeys-17975299796640768.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/nhp-ibd-model-chronic-enterocolitis-17975299968427008.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/why-positive-control-drugs-matter-in-autoimmun-17975300086703104.html 2026-09-10T15:42:21+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/when-to-introduce-nhp-studies-autoimmune-drug-17975300351747072.html 2026-08-23T09:30:37+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/webinar-nhp-behavioratlas-17975323260986368.html 2026-08-01T18:51:03+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/midd-and-nhp-efficacy-models-in-drug-17984599594656768.html 2026-08-01T18:51:09+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/behavior-in-rhesus-17984599710065664.html 2026-08-05T21:00:22+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/pk-biomarkers-preclinical-drug-development-17990390678430720.html 2026-09-01T21:39:33+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/webinar-recap-digital-behavioral-phenotyping-17993212719866880.html 2026-09-01T21:39:40+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/molecular-imaging-in-nhp-model-webinar-18003229835682816.html 2026-09-01T21:39:35+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/pbpk-vs-compartmental-models-drug-development-18003229907428352.html 2026-09-01T21:39:45+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/3d-ai-tracking-nhp-behavior-18015201591485440.html 2026-08-23T11:21:05+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/pet-biodistribution-nhp-studies-18015306762036224.html 2026-09-01T21:33:29+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/quantitative-pet-target-engagement-in-nhps-for-18021142691898368.html 2026-09-01T11:36:10+08:00 weekly 0.8 https://nl.prisysbiotech.com/news/animal-models-succeed-or-fail-in-drug-dev-18028056109818880.html